Switzerland
# |
Name |
EBIT |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 17.76 B
|
Dec. 31, 2023 | USD 333.72 | 0.27% |
|
Switzerland |
|
2 |
USD 14.65 B
|
Dec. 31, 2024 | USD 104.72 | -0.12% |
|
Switzerland |
|
3 |
USD 984.37 M
|
Dec. 31, 2024 | USD 651.30 | 2.02% |
|
Switzerland |
|
4 |
USD 442.59 M
|
Dec. 31, 2023 | USD 138.90 | -2.86% |
|
Switzerland |
|
5 |
USD 332.00 M
|
Dec. 31, 2023 | USD 46.21 | -3.47% |
|
Switzerland |
|
6 |
USD 242.20 M
|
Dec. 31, 2023 | USD 88.99 | -0.28% |
|
Switzerland |
|
7 |
USD 189.88 M
|
Dec. 31, 2023 | USD 1.12 K | -0.26% |
|
Switzerland |
|
8 |
USD 160.08 M
|
Dec. 31, 2023 | USD 250.45 | -3.26% |
|
Switzerland |
|
9 |
USD 153.67 M
|
Dec. 31, 2023 | USD 62.45 | -2.60% |
|
Switzerland |
|
10 |
USD 96.34 M
|
March 31, 2024 | USD 382.54 | -3.00% |
|
Switzerland |
|
11 |
USD 90.42 M
|
Dec. 31, 2023 | USD 17.87 | -4.83% |
|
Switzerland |
|
12 |
USD 84.45 M
|
Dec. 31, 2023 | USD 126.21 | -1.33% |
|
Switzerland |
|
13 |
USD 38.50 M
|
Dec. 31, 2023 | USD 1.14 K | -1.12% |
|
Switzerland |
|
14 |
USD 25.66 M
|
Dec. 31, 2023 | USD 43.76 | -1.99% |
|
Switzerland |
|
15 |
USD 25.42 M
|
Dec. 31, 2023 | USD 3.57 | -5.82% |
|
Switzerland |
|
16 |
USD 21.20 M
|
Dec. 31, 2023 | USD 161.30 | -1.97% |
|
Switzerland |
|
17 |
USD 20.14 M
|
Dec. 31, 2023 | USD 60.16 | -1.72% |
|
Switzerland |
|
18 |
USD 19.00 M
|
Dec. 31, 2023 | USD 13.36 | -0.81% |
|
Switzerland |
|
19 |
USD 13.59 M
|
Dec. 31, 2023 | USD 74.55 | -2.22% |
|
Switzerland |
|
20 |
USD -15.29 M
|
Dec. 31, 2023 | USD 15.53 | -0.65% |
|
Switzerland |
|
21 |
USD -15.63 M
|
Dec. 31, 2023 | USD 24.30 | -3.46% |
|
Switzerland |
|
22 |
USD -54.12 M
|
Dec. 31, 2023 | USD 45.99 | -2.40% |
|
Switzerland |
|
23 |
USD -58.08 M
|
Dec. 31, 2023 | USD 27.36 | -2.78% |
|
Switzerland |
|
24 |
USD -64.19 M
|
Dec. 31, 2023 | USD 2.75 | 1.85% |
|
Switzerland |
|
25 |
USD -73.56 M
|
Dec. 31, 2023 | USD 5.05 | -4.17% |
|
Switzerland |
|
26 |
USD -116.40 M
|
Dec. 31, 2023 | USD 21.72 | -0.35% |
|
Switzerland |
|
27 |
USD -150.03 M
|
Dec. 31, 2023 | USD 1.68 | -2.33% |
|
Switzerland |
|
28 |
USD -222.54 M
|
Dec. 31, 2023 | USD 41.59 | -1.07% |
|
Switzerland |
The Healthcare company in Switzerland with the highest EBIT is Roche Holding AG (Swiss Stock Exchange: RO.SW) at USD 17.76 B.
The Healthcare company in Switzerland with the lowest EBIT is CRISPR Therapeutics AG (NasdaqGM: CRSP) at USD -222.54 M.
The top 10 Healthcare companies in Switzerland by EBIT are Roche Holding AG, Novartis AG, Lonza Group AG, Straumann Holding AG, Sandoz Group AG, Galenica AG, Siegfried Holding AG, Tecan Group AG, Bachem Holding AG and Ypsomed Holding AG.
The bottom 10 Healthcare companies in Switzerland by EBIT are CRISPR Therapeutics AG, ADC Therapeutics SA, DocMorris AG, Molecular Partners AG, AC Immune SA, PolyPeptide Group AG, MoonLake Immunotherapeutics, Kuros Biosciences AG, Aevis Victoria SA and Medartis Holding AG.